 | • レポートコード：MRC23Q36297 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の予防医療技術市場について調査・分析し、世界の予防医療技術市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（遺伝子検査/スクリーニング、ワクチン）、用途別セグメント分析（大人、子供）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、23andMe、MyHeritage、Myriad Genetics、Quest Diagnostics、Medtronic、Abbott、Merck、GlaxoSmithKline、Sanofi、Pfizer、China National Biotecなどが含まれています。世界の予防医療技術市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、予防医療技術市場規模を推定する際に考慮しました。本レポートは、予防医療技術の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、予防医療技術に関するビジネス上の意思決定に役立てることを目的としています。 ・予防医療技術市場の概要 - 予防医療技術のタイプ別セグメント - 世界の予防医療技術市場規模：タイプ別分析（遺伝子検査/スクリーニング、ワクチン） - 予防医療技術の用途別セグメント - 世界の予防医療技術市場規模：用途別分析（大人、子供） - 世界の予防医療技術市場規模予測（2018年-2029年） ・予防医療技術市場の成長トレンド - 予防医療技術の地域別市場規模（2018年-2029年） - 予防医療技術市場ダイナミクス - 予防医療技術の業界動向 - 予防医療技術市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：遺伝子検査/スクリーニング、ワクチン - 世界の予防医療技術のタイプ別市場規模（2018年-2023年） - 世界の予防医療技術のタイプ別市場規模（2024年-2029年） ・用途別セグメント：大人、子供 - 世界の予防医療技術の用途別市場規模（2018年-2023年） - 世界の予防医療技術の用途別市場規模（2024年-2029年） ・予防医療技術の地域別市場規模 - 北米の予防医療技術市場規模（2018年-2029年） - アメリカの予防医療技術市場規模（2018年-2029年） - ヨーロッパの予防医療技術市場規模（2018年-2029年） - アジア太平洋の予防医療技術市場規模（2018年-2029年） - 中国の予防医療技術市場規模（2018年-2029年） - 日本の予防医療技術市場規模（2018年-2029年） - 韓国の予防医療技術市場規模（2018年-2029年） - インドの予防医療技術市場規模（2018年-2029年） - オーストラリアの予防医療技術市場規模（2018年-2029年） - 中南米の予防医療技術市場規模（2018年-2029年） - 中東・アフリカの予防医療技術市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 23andMe、MyHeritage、Myriad Genetics、Quest Diagnostics、Medtronic、Abbott、Merck、GlaxoSmithKline、Sanofi、Pfizer、China National Biotec ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Preventive Healthcare Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Preventive Healthcare Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Preventive Healthcare Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Preventive Healthcare Technology in Adults is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Preventive Healthcare Technology include 23andMe, MyHeritage, Myriad Genetics, Quest Diagnostics, Medtronic, Abbott, Merck, GlaxoSmithKline and Sanofi, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Preventive Healthcare Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventive Healthcare Technology.
The Preventive Healthcare Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Preventive Healthcare Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preventive Healthcare Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
23andMe
MyHeritage
Myriad Genetics
Quest Diagnostics
Medtronic
Abbott
Merck
GlaxoSmithKline
Sanofi
Pfizer
China National Biotec
Segment by Type
Gene Testing & Screening
Vaccines
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preventive Healthcare Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preventive Healthcare Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gene Testing & Screening
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Preventive Healthcare Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preventive Healthcare Technology Market Perspective (2018-2029)
2.2 Preventive Healthcare Technology Growth Trends by Region
2.2.1 Global Preventive Healthcare Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Preventive Healthcare Technology Historic Market Size by Region (2018-2023)
2.2.3 Preventive Healthcare Technology Forecasted Market Size by Region (2024-2029)
2.3 Preventive Healthcare Technology Market Dynamics
2.3.1 Preventive Healthcare Technology Industry Trends
2.3.2 Preventive Healthcare Technology Market Drivers
2.3.3 Preventive Healthcare Technology Market Challenges
2.3.4 Preventive Healthcare Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preventive Healthcare Technology Players by Revenue
3.1.1 Global Top Preventive Healthcare Technology Players by Revenue (2018-2023)
3.1.2 Global Preventive Healthcare Technology Revenue Market Share by Players (2018-2023)
3.2 Global Preventive Healthcare Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preventive Healthcare Technology Revenue
3.4 Global Preventive Healthcare Technology Market Concentration Ratio
3.4.1 Global Preventive Healthcare Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preventive Healthcare Technology Revenue in 2022
3.5 Preventive Healthcare Technology Key Players Head office and Area Served
3.6 Key Players Preventive Healthcare Technology Product Solution and Service
3.7 Date of Enter into Preventive Healthcare Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preventive Healthcare Technology Breakdown Data by Type
4.1 Global Preventive Healthcare Technology Historic Market Size by Type (2018-2023)
4.2 Global Preventive Healthcare Technology Forecasted Market Size by Type (2024-2029)
5 Preventive Healthcare Technology Breakdown Data by Application
5.1 Global Preventive Healthcare Technology Historic Market Size by Application (2018-2023)
5.2 Global Preventive Healthcare Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Preventive Healthcare Technology Market Size (2018-2029)
6.2 North America Preventive Healthcare Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Preventive Healthcare Technology Market Size by Country (2018-2023)
6.4 North America Preventive Healthcare Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preventive Healthcare Technology Market Size (2018-2029)
7.2 Europe Preventive Healthcare Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Preventive Healthcare Technology Market Size by Country (2018-2023)
7.4 Europe Preventive Healthcare Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preventive Healthcare Technology Market Size (2018-2029)
8.2 Asia-Pacific Preventive Healthcare Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Preventive Healthcare Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Preventive Healthcare Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preventive Healthcare Technology Market Size (2018-2029)
9.2 Latin America Preventive Healthcare Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Preventive Healthcare Technology Market Size by Country (2018-2023)
9.4 Latin America Preventive Healthcare Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preventive Healthcare Technology Market Size (2018-2029)
10.2 Middle East & Africa Preventive Healthcare Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Preventive Healthcare Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Preventive Healthcare Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe
11.1.1 23andMe Company Detail
11.1.2 23andMe Business Overview
11.1.3 23andMe Preventive Healthcare Technology Introduction
11.1.4 23andMe Revenue in Preventive Healthcare Technology Business (2018-2023)
11.1.5 23andMe Recent Development
11.2 MyHeritage
11.2.1 MyHeritage Company Detail
11.2.2 MyHeritage Business Overview
11.2.3 MyHeritage Preventive Healthcare Technology Introduction
11.2.4 MyHeritage Revenue in Preventive Healthcare Technology Business (2018-2023)
11.2.5 MyHeritage Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Detail
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Preventive Healthcare Technology Introduction
11.3.4 Myriad Genetics Revenue in Preventive Healthcare Technology Business (2018-2023)
11.3.5 Myriad Genetics Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Preventive Healthcare Technology Introduction
11.4.4 Quest Diagnostics Revenue in Preventive Healthcare Technology Business (2018-2023)
11.4.5 Quest Diagnostics Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Preventive Healthcare Technology Introduction
11.5.4 Medtronic Revenue in Preventive Healthcare Technology Business (2018-2023)
11.5.5 Medtronic Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Preventive Healthcare Technology Introduction
11.6.4 Abbott Revenue in Preventive Healthcare Technology Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Preventive Healthcare Technology Introduction
11.7.4 Merck Revenue in Preventive Healthcare Technology Business (2018-2023)
11.7.5 Merck Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Preventive Healthcare Technology Introduction
11.8.4 GlaxoSmithKline Revenue in Preventive Healthcare Technology Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Preventive Healthcare Technology Introduction
11.9.4 Sanofi Revenue in Preventive Healthcare Technology Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Preventive Healthcare Technology Introduction
11.10.4 Pfizer Revenue in Preventive Healthcare Technology Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 China National Biotec
11.11.1 China National Biotec Company Detail
11.11.2 China National Biotec Business Overview
11.11.3 China National Biotec Preventive Healthcare Technology Introduction
11.11.4 China National Biotec Revenue in Preventive Healthcare Technology Business (2018-2023)
11.11.5 China National Biotec Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details